|
|||||
|
|
AmBisome: an overview of current use. |
|
| Authors: | H Myint |
| Affiliation: | Department of Haematology and Oncology, Royal Bournemouth Hospital. |
| Abstract: | Although amphotericin B has been the gold standard in treating systemic fungal infections, its use is limited by side-effects including nephrotoxicity. In contrast the empiric or therapeutic use of AmBisome is better tolerated, with less nephrotoxicity. |
| Keywords: | |